Annual Net Income:
-$463.66M-$135.59M(-41.33%)Summary
- As of today, RXRX annual net profit is -$463.66 million, with the most recent change of -$135.59 million (-41.33%) on December 31, 2024.
- During the last 3 years, RXRX annual net income has fallen by -$277.18 million (-148.64%).
- RXRX annual net income is now -649.30% below its all-time high of -$61.88 million, reached on December 31, 2019.
Performance
RXRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$162.25M+$9.64M(+5.61%)Summary
- As of today, RXRX quarterly net profit is -$162.25 million, with the most recent change of +$9.64 million (+5.61%) on September 30, 2025.
- Over the past year, RXRX quarterly net income has dropped by -$66.41 million (-69.29%).
- RXRX quarterly net income is now -780.66% below its all-time high of -$18.42 million, reached on March 31, 2020.
Performance
RXRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$715.54M-$66.41M(-10.23%)Summary
- As of today, RXRX TTM net profit is -$715.54 million, with the most recent change of -$66.41 million (-10.23%) on September 30, 2025.
- Over the past year, RXRX TTM net income has dropped by -$337.79 million (-89.42%).
- RXRX TTM net income is now -3783.75% below its all-time high of -$18.42 million, reached on March 31, 2020.
Performance
RXRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RXRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -41.3% | -69.3% | -89.4% |
| 3Y3 Years | -148.6% | -168.4% | -189.8% |
| 5Y5 Years | -649.3% | -579.6% | -722.4% |
RXRX Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -148.6% | at low | -182.2% | +19.9% | -198.8% | at low |
| 5Y | 5-Year | -649.3% | at low | -529.7% | +19.9% | -722.4% | at low |
| All-Time | All-Time | -649.3% | at low | -780.7% | +19.9% | -3783.8% | at low |
RXRX Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$162.25M(+5.6%) | -$715.54M(-10.2%) |
| Jun 2025 | - | -$171.90M(+15.1%) | -$649.13M(-12.9%) |
| Mar 2025 | - | -$202.49M(-13.2%) | -$574.77M(-24.0%) |
| Dec 2024 | -$463.66M(-41.3%) | -$178.91M(-86.7%) | -$463.66M(-22.7%) |
| Sep 2024 | - | -$95.84M(+1.7%) | -$377.75M(-0.8%) |
| Jun 2024 | - | -$97.54M(-6.7%) | -$374.93M(-5.9%) |
| Mar 2024 | - | -$91.37M(+1.7%) | -$354.11M(-7.9%) |
| Dec 2023 | -$328.07M(-37.0%) | -$93.00M(+0.0%) | -$328.07M(-12.1%) |
| Sep 2023 | - | -$93.02M(-21.2%) | -$292.56M(-12.5%) |
| Jun 2023 | - | -$76.73M(-17.4%) | -$259.99M(-4.5%) |
| Mar 2023 | - | -$65.33M(-13.6%) | -$248.82M(-3.9%) |
| Dec 2022 | -$239.48M | -$57.49M(+4.9%) | -$239.48M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$60.45M(+7.8%) | -$246.92M(-5.6%) |
| Jun 2022 | - | -$65.56M(-17.1%) | -$233.90M(-10.5%) |
| Mar 2022 | - | -$55.98M(+13.8%) | -$211.74M(-13.5%) |
| Dec 2021 | -$186.48M(-114.3%) | -$64.93M(-36.9%) | -$186.48M(-26.6%) |
| Sep 2021 | - | -$47.43M(-9.3%) | -$147.31M(-19.0%) |
| Jun 2021 | - | -$43.40M(-41.3%) | -$123.76M(-24.6%) |
| Mar 2021 | - | -$30.72M(-19.2%) | -$99.30M(-14.1%) |
| Dec 2020 | -$87.01M(-40.6%) | - | - |
| Dec 2020 | - | -$25.77M(-7.9%) | -$87.01M(-42.1%) |
| Sep 2020 | - | -$23.87M(-26.0%) | -$61.24M(-63.9%) |
| Jun 2020 | - | -$18.94M(-2.8%) | -$37.37M(-102.8%) |
| Mar 2020 | - | -$18.42M | -$18.42M |
| Dec 2019 | -$61.88M | - | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual net profit?
- What is the all-time high annual net income for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Recursion Pharmaceuticals, Inc. TTM net profit?
- What is the all-time high TTM net income for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual net profit?
The current annual net income of RXRX is -$463.66M
What is the all-time high annual net income for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual net profit is -$61.88M
What is Recursion Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, RXRX annual net profit has changed by -$135.59M (-41.33%)
What is Recursion Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of RXRX is -$162.25M
What is the all-time high quarterly net income for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly net profit is -$18.42M
What is Recursion Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, RXRX quarterly net profit has changed by -$66.41M (-69.29%)
What is Recursion Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of RXRX is -$715.54M
What is the all-time high TTM net income for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high TTM net profit is -$18.42M
What is Recursion Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, RXRX TTM net profit has changed by -$337.79M (-89.42%)